| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8286199 | Parkinsonism & Related Disorders | 2014 | 4 Pages |
Abstract
A therapeutic trial of tetrabenazine should be considered in patients with M-D, especially before consideration of deep brain stimulation. An adequately powered multi-center, double-blind study of tetrabenazine will be required to determine the relative contributions of tetrabenazine therapy to myoclonus, dystonia, quality of life, and activities of daily living in patients with M-D.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Angelo Y. Luciano, H.A. Jinnah, Ronald F. Pfeiffer, Daniel D. Truong, Martha A. Nance, Mark S. LeDoux,